RECRUITING

Blood Specimen Collection For Laboratory Assay Research

Conditions

General; Metabolic Disorder Sexual Dysfunction Hair Loss Pathology

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.

Official Title

Blood Specimen Collection For Laboratory Assay Research

Quick Facts

Study Start:2023-08-16

Study Completion:2033-08-15

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06046651

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Not specified

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Any gender, in good general health * Must be 18 years old or older, inclusive at enrollment * Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional * Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire * Must be able to read, speak and understand English * Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator.	* Individuals who are unable to provide a blood sample due to any illness * Individuals participating in another research study, that the Investigator feels may compromise study outcomes * Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes * Individuals who are unlikely to be available for the duration of the study

Inclusion Criteria

Exclusion Criteria

* Any gender, in good general health
* Must be 18 years old or older, inclusive at enrollment
* Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional
* Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire
* Must be able to read, speak and understand English
* Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator.

* Individuals who are unable to provide a blood sample due to any illness
* Individuals participating in another research study, that the Investigator feels may compromise study outcomes
* Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes
* Individuals who are unlikely to be available for the duration of the study

Contacts and Locations

Study Contact

Nitin Vaswani, MD

CONTACT

7577263449

nitin.vaswani@ro.co

Principal Investigator

Nitin Vaswani, MD

PRINCIPAL_INVESTIGATOR

Principal Investigator

Study Locations (Sites)

Roman Health Ventures Study Site

San Francisco, California, 94107

United States

Collaborators and Investigators

Sponsor: Roman Health Ventures Inc.

Nitin Vaswani, MD, PRINCIPAL_INVESTIGATOR, Principal Investigator

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-16

Study Completion Date2033-08-15

Study Record Updates

Study Start Date2023-08-16

Study Completion Date2033-08-15

Terms related to this study

Additional Relevant MeSH Terms

General; Metabolic Disorder
Sexual Dysfunction
Hair Loss
Pathology